Neuro Chemistry
NT: chemical released by a neuron onto a target with an excitatory or inhibitory effect
outside the CNS many of these chemicals circulate in the blood stream as hormones
_ in the cell body according to instruction contained in the DNA, transported on microtubules to axon terminal
complex causes some vesicles into empty the synapse and others get ready to empty their contents
autoreceptors–“self-receptor” on the presynaptic membrane that responds to the transmitter that the neuron releases
linked to a G protein that can affect other receptors or act with second messengers to affect other cellular processes
activated by a NT
degradation by enzymes in the synaptic cleft
reuptake into the presynaptic neuron for subsequent re-use
taken up by neighboring glial cells
*not mutually exclusive
typically located on dendrites
round vesicles
dense material on membranes
wide cleft
large active zone
typically located on cell body
flat vesicles
sparse material on membranes
narrow cleft
small active zone
when the neuron is active the chemical must be released and produce a response in a target
the same responses must be obtained when the chemical is experimentally placed on the target
a mechanism must exist for removing the chemical from its site of action after its work is done
synthesized from dietary nutrients and packaged ready for use in axon terminals
ex.: ACh, DA, NE,EP, Glu, GABA, Gly, histamine
_ restricts the rate at which all the catecholamines can by synthesized
GABA-main inhibitory transmitter
cannot pass blood-brain barrier–synthesized within the cell using glutamine released by glial cells, glial cells take up released glutamate and transform to glutamine
synthesized from mRNA on instructions from the cell’s DNA
do not bind to ion channels; do not have direct effects on the voltage of the postsynaptic membrane, act indirectly via G-protein coupled receptors
easily crosses cell membrane
support metabolic processes
excites skeletal muscles to cause contractions
ACh produced in nuclei in midbrain and basal forebrain
both NE and ACh have excitatory effects on some organs and inhibitory effects on others
dopaminergic x2
noradrenergic
serotonergic
cell bodies are located in a nucleus in the brainstem and their axons are distributed through a wide region of the brain
maintaining neuronal excitability–helps maintain working electroencephalographic pattern
Alzheimer’s disease–linked to decreased ACh synthesis, treated with acetylcholinesterase inhibitors
parkinson’s disease treated with L-dopa
mesolimbocortial–originates in ventral tegmentum, projects to nucleus accumbens, basal forebrain, frontal cortex, reward, motivation, addiction
increased DA= schizophrenia
decreased DA= ADHD, treat with DA stimulants
emotion
decreased NE= major depression
increased NE= mania
maintaining wakefulness
learning
increased 5-HT= OCD
decreased 5-HT= depression
abnormalities in brainstem 5-HT neurons linked to sleep apnea and SIDS
glial cells provide a route for the exchange of food and waste between capillaries and the brain’s extracellular fluid
partial agonists produce a medium response regardless of dose
the does ate which the drug shows half of its maximal effect is the _
a drug that has comparable effects at lower doses is more potent
drugs with wider _ are safer
activities of brain cells adjust to minimize effects of the substance
suggests that the two drugs affect a common nervous system target
GABA
benzodiaxepines–antianxiety agents
barbiturates–produce sedation and sleep, also general anesthesia, coma, death
dissociate anesthetics–group of sedative-hypnotics developed as anesthetics, produce altered states and hallucinations (GHB, ketamine, date rape drugs)
alcohol–similar neurochemical effects as barbiturates, GABAa receptors and increases inhibitory effect, also stimulates dopamine pathways causing euphoric effects, chronic use causes liver damage and thiamine deficiency
second generation-weakly block D2 receptors but also block serotonin 5-HT2 receptors, reduce negative symptoms, affect motivation and reduce agitation but may result in weight gain
evidence–antipsychotic drugs block D2 receptors, amphetamine promotes release of _ and can produce symptoms similar to schizophrenia
tricyclic _–first generation _ with a chemical structure characterized by 3 rings that block 5-HT reuptake transporter proteins
second-generation _–action is similar to first generation but is more selective, SSRIs, block the reuptake of serotonin into the presynaptic terminal
mutes the intensity of one pole of the disorder thus making the other pole less likely to recur
mechanism is not well understood–lithium may increase serotonin release, valproate may stimulate GABA activity
2 natural sources– opium used for thousands of years to produce euphoria, analgesia, sleep, and relief from diarrhea and coughing, the brain–peptides in the body that have opioid like effects are collectively called endorphins
3 classes–endomorphins, enkephalins, dynorphins
codeine
morphine
some synthetic _ prescribed for clinical use in pain management are hydromorphone, levorphanol, methadone
competitive inhibitors can be used to treat opioid addiction after the person has recovered from withdrawal symptoms–nalorphine and nalozone
_ ingestion produces relaxation, sleep, euphoria, constipation, respiratory depression, decreased blood pressure, pupil constriction, hypothermia
more fat soluble and penetrates the BBB faster than morphine, therefore produces very rapid pain relief
psychedelic and hallucinogenic stimulants affect perception and produce hallucinations
general stimulants mainly affect mood
rapid administration of _ is most likely to be associated with addiction
blocks dopamin reuptake
powder is snorted or injected
derivates such as novocaine are used as local anesthetics–reduce cell’s permeability to Na+ thereby reducing nerve conduction
both mechanisms increase the amount of DA available in synapses to stimulate DA receptors
some uses–initially an asthma treatment, study aid, improvement of alertness and productivity, weight-loss aid
neurotoxic–causes brain damage with prolonged use, damages both DA and 5HT neurons
caffeine–inhibits the enzyme that normally breaks down the second messenger cyclic AMP, increase in cAMP leads to an increase in glucose production within cells, which makes more energy available and allows for higher rates of cellular activity, blocks the effect of adenosine an endogenous neuromodulator that normally inhibits catecholamine release
ACh- atropine, nicotine
NE- mescaline
HT5- LSD, psilocybin, ecstacy
Anandimide- THC
Glutamate- PCP, ketamine
have diverse neural action including those on NE, HT5, ACh and opiate systems
many have potential clinical uses for treatment of mental health disorders–OCD, anxiety, depression, PTSD
nicotine–increases heart rate, blood pressure, hydrocholiric acid secretion, and bowel activity, acts as an agonist on nicotinic ACh receptors in the body and brain, rewarding effects are mediated by receptors in ventral tegmnetal area
ecstasy elevates _ concentrations by blocking reuptake and stimulating release
chronic use can cause depression, memory disturbances and alters the structure and function of _ neurons
2 cannabinoid receptors (metabotropic)– CB1 only in the CNS, CB2 prominent in the immune system
they exert part of their action by blocking glutamate NMDA receptors involved in learning
many _ like substances kill neurons–influx of Ca2+ into the cell which through second messengers activates a suicide gene leading to apoptosis